190 related articles for article (PubMed ID: 32486427)
1. Transiently Expressed Mistletoe Lectin II in
Mazalovska M; Kouokam JC
Molecules; 2020 May; 25(11):. PubMed ID: 32486427
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the recombinant A-chain of a type II ribosome-inactivating protein (RIP) from Viscum album coloratum and structural basis on its ribosome-inactivating activity and the sugar-binding properties of the B-chain.
Ye W; Nanga RP; Kang CB; Song JH; Song SK; Yoon HS
J Biochem Mol Biol; 2006 Sep; 39(5):560-70. PubMed ID: 17002877
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album).
Park JH; Hyun CK; Shin HK
Cancer Lett; 1999 May; 139(2):207-13. PubMed ID: 10395180
[TBL] [Abstract][Full Text] [Related]
5. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt.
Choi SH; Lyu SY; Park WB
Arch Pharm Res; 2004 Jan; 27(1):68-76. PubMed ID: 14969342
[TBL] [Abstract][Full Text] [Related]
6. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album).
Peumans WJ; Verhaert P; Pfüller U; Van Damme EJ
FEBS Lett; 1996 Nov; 396(2-3):261-5. PubMed ID: 8914999
[TBL] [Abstract][Full Text] [Related]
7. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins.
Frantz M; Jung ML; Ribereau-Gayon G; Anton R
Arzneimittelforschung; 2000 May; 50(5):471-8. PubMed ID: 10858875
[TBL] [Abstract][Full Text] [Related]
8. Comparison of microbial and transient expression (tobacco plants and plant-cell packs) for the production and purification of the anticancer mistletoe lectin viscumin.
Gengenbach BB; Keil LL; Opdensteinen P; Müschen CR; Melmer G; Lentzen H; Bührmann J; Buyel JF
Biotechnol Bioeng; 2019 Sep; 116(9):2236-2249. PubMed ID: 31140580
[TBL] [Abstract][Full Text] [Related]
9. Preparation of alginate/chitosan microcapsules and enteric coated granules of mistletoe lectin.
Lyu SY; Kwon YJ; Joo HJ; Park WB
Arch Pharm Res; 2004 Jan; 27(1):118-26. PubMed ID: 14969350
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
11. A new gene encoding the ribosome-inactivating protein from mistletoe extracts.
Tonevitsky AG; Agapov II; Pevzner IB; Maluchenko NV; Moisenovich MM; Palmer RA; Yurkova M; Pfüller K; Pfüller U
Arzneimittelforschung; 2004; 54(4):242-9. PubMed ID: 15146937
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
13. Primary structure and molecular modeling of mistletoe lectin I from Viscum album.
Eschenburg S; Krauspenhaar R; Mikhailov A; Stoeva S; Betzel C; Voelter W
Biochem Biophys Res Commun; 1998 Jun; 247(2):367-72. PubMed ID: 9642133
[TBL] [Abstract][Full Text] [Related]
14. Study of heterogeneity of lectins in mistletoe preparations by monoclonal antibodies to their A-subunits.
Tonevitsky AG; Agapov I; Temiakov D; Moisenovich M; Maluchenko N; Solopova O; Würzner G; Pfueller U
Arzneimittelforschung; 1999 Nov; 49(11):970-5. PubMed ID: 10604051
[TBL] [Abstract][Full Text] [Related]
15. Comparison of properties of mistletoe lectin I A-chain and ricin B-chain conjugate with native toxins.
Tonevitsky AG; Toptygin AYu ; Shamshiev AT; Agapov II; Ershova EV; Pfuller U; Pfuller K
FEBS Lett; 1993 Dec; 336(1):100-2. PubMed ID: 8262189
[TBL] [Abstract][Full Text] [Related]
16. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
Mengs U; Göthel D; Leng-Peschlow E
Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
[TBL] [Abstract][Full Text] [Related]
17. Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells.
Mulsow K; Enzlein T; Delebinski C; Jaeger S; Seifert G; Melzig MF
PLoS One; 2016; 11(4):e0153825. PubMed ID: 27088729
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain.
Eck J; Langer M; Möckel B; Baur A; Rothe M; Zinke H; Lentzen H
Eur J Biochem; 1999 Sep; 264(3):775-84. PubMed ID: 10491123
[TBL] [Abstract][Full Text] [Related]
19. Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro.
Hostanska K; Hajto T; Fischer J; Mengs U; Weber K; Lentzen H; Saller R
Cancer Detect Prev; 1999; 23(6):511-23. PubMed ID: 10571662
[TBL] [Abstract][Full Text] [Related]
20. Complete amino acid sequence of the B chain of mistletoe lectin I.
Soler MH; Stoeva S; Voelter W
Biochem Biophys Res Commun; 1998 May; 246(3):596-601. PubMed ID: 9618256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
